John F. Crowley, Chairman & CEO, Amicus Therapeutics, to Keynote CBI's 5th Annual Rare Disease Leadership Summit
BOSTON, May 5 /PRNewswire/ -- The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to host their 5th Annual Rare Disease Leadership Summit, taking place at the Ritz-Carlton Pentagon City in Arlington, VA on July 13-14, 2010.
John F. Crowley, Chairman & CEO, Amicus Therapeutics, is scheduled to Keynote the summit on the topic of "Turning Passion into Tangible Science - A Race Towards a Cure." Mr. Crowley will also be taking part in a signing of his book, "Chasing Miracles," inspiration of the feature film Extraordinary Measures. Agenda also includes updates from FDA, NIH, NORD, Kakkis EveryLife Foundation and companies including:
Alexion Pharmaceuticals Inc. * Centric Health Resources, Inc. * GlaxoSmithKline * Lundbeck Inc. * Millennium: The Takeda Oncology Company * NPS Pharmaceuticals * Siren Interactive * Shire * Synageva Biopharma * Tufts Center for Drug Development
This summit assembles industry stakeholders and key thought leaders in the rare disease and drug development arena for an energetic and timely discussion on recent initiatives, reimbursement and patient access challenges, commercialization partnerships and more.
Current Sponsors: Siren Interactive, Centric Health Resources, Almac Pharma Services, Medical Marketing Economics |
|
In Association With: NORD |
|
For more information on this event, please visit: http://www.cbinet.com/raredisease, call 800-817-8601 or email: [email protected]. For media partnership opportunities, please contact Monali Shah of CBI at 339.298.2285.
About John F. Crowley, Chairman & CEO, Amicus Therapeutics
John F. Crowley is an American business and social entrepreneur - and a true inspiration. John embarked on his journey as an entrepreneur to find a treatment that would save his kids' lives - and the lives of thousands of others, parlaying his personal struggles and determination into a series of highly successful biotech business ventures.
About CBI:
A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy and decision makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com.
This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.
SOURCE CBI Research, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
![icon3](/content/dam/newsfeatured/icon3.png)
Newsrooms &
Influencers
![icon1](/content/dam/newsfeatured/icon1.png)
Digital Media
Outlets
![icon2](/content/dam/newsfeatured/icon2.png)
Journalists
Opted In
Share this article